当前位置： SCI文献检索 > ENDOCRINOLOGY期刊下所有文献 > Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization.

Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization.

Abstract：

:Male Sprague-Dawley rats were infused continuously for 13 days with vehicle or 75 pmol (31.2 ng)/day 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] by means of Alzet osmotic minipumps implanted s.c. Animals infused with 1,25-(OH)2D3 exhibited mild hypercalcemia (11.2 vs. 10.2 mg/dl in controls), a 136% increase in the serum concentration of 1,25-(OH)2D3 (187 vs. 79 pg/ml), and a 59% decrease in serum 25-hydroxyvitamin D (12 vs. 29 ng/ml). The proximal tibial metaphysis of these animals was characterized by increased trabecular bone volume (15% vs. 6.5%), osteoid accumulation (4.2% vs. 0.1%), increased osteoblast surface and number (31% and 19/mm vs. 21% and 14/mm, respectively), and decreased osteoclast surface and number (11% and 2/mm vs. 36% and 6/mm, respectively). Similar but less striking changes were seen in the lumbar vertebra. Increases in the fat-free weight and calcium content of the tibia and lumbar vertebra were consistent with the increase in trabecular bone volume after 1,25-(OH)2D3 infusion. However, tetracycline labeling and the incorporation of 45Ca in these bones were reduced by 1,25-(OH)2D3 infusion. In addition, mineralization lag time was prolonged in the lumbar vertebrae of 1,25-(OH)2D3-infused rats. Our findings indicate that chronic 1,25-(OH)2D3 administration increases bone mass, but at the cost of impaired bone mineralization.

journal_name

Endocrinology

journal_title

Endocrinology

authors

Wronski TJ,Halloran BP,Bikle DD,Globus RK,Morey-Holton ER

doi

10.1210/endo-119-6-2580

subject

Has Abstract

pub_date

1986-12-01 00:00:00

pages

2580-5

issue

6

eissn

0013-7227

issn

1945-7170

journal_volume

119

pub_type

杂志文章

相关文献

ENDOCRINOLOGY文献大全